344 related articles for article (PubMed ID: 18271437)
1. ESA payment changes: chasing a moving target.
Sargent JA
Nephrol News Issues; 2008 Jan; 22(1):36-7. PubMed ID: 18271437
[No Abstract] [Full Text] [Related]
2. Finding a rational approach to ESA therapy--for payers and patients.
Messana A
Nephrol News Issues; 2007 Sep; 21(10):54, 56. PubMed ID: 17918481
[No Abstract] [Full Text] [Related]
3. Erythropoietin claims monitoring policy: implications of the October 2006 update continuing.
Messana T
Nephrol Nurs J; 2006; 33(6):660-3; quiz 664-5. PubMed ID: 17219727
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin claims monitoring policy: implications for clinical practice.
Messana T
Nephrol Nurs J; 2006; 33(2):209-13, 222; quiz 214-5. PubMed ID: 16613415
[TBL] [Abstract][Full Text] [Related]
5. Report from the University Healthsystem Consortium.
Int J Technol Assess Health Care; 1999; 15(2):437-8. PubMed ID: 10507201
[No Abstract] [Full Text] [Related]
6. Rebates for anti-anemia drugs draw response from FDA, CMS.
Sipkoff M
Manag Care; 2007 Jun; 16(6):17-8. PubMed ID: 17682732
[No Abstract] [Full Text] [Related]
7. Has economics overshadowed our clinical approaches to EPO?
Sullivan JD
Nephrol News Issues; 2007 Jul; 21(8):56, 58-9, 68. PubMed ID: 17688233
[No Abstract] [Full Text] [Related]
8. It's about time.
Fein D
Nephrol News Issues; 2007 Dec; 21(12):18. PubMed ID: 18038747
[No Abstract] [Full Text] [Related]
9. It's about time.
Coutts LR
Nephrol News Issues; 2007 Oct; 21(11):12. PubMed ID: 17970503
[No Abstract] [Full Text] [Related]
10. The changing tide in ESRD care.
Sullivan JD
Nephrol News Issues; 2010 Jul; 24(8):24, 27-8. PubMed ID: 20695319
[No Abstract] [Full Text] [Related]
11. Re-engineering the ESRD Program amid Medicare reform.
Neumann ME
Nephrol News Issues; 2005 Jan; 19(2):40-1. PubMed ID: 15717573
[No Abstract] [Full Text] [Related]
12. Medicare changes: what every nurse must know.
Sincox AK
Mich Nurse; 2008; 81(3):6-7, 21. PubMed ID: 18777675
[No Abstract] [Full Text] [Related]
13. Finding the magic formula for ESA use.
Neumann ME
Nephrol News Issues; 2010 May; 24(6):8. PubMed ID: 20509399
[No Abstract] [Full Text] [Related]
14. Gearing up for changes at HCFA: get involved and make a difference.
Newman DK
Ostomy Wound Manage; 1998 Dec; 44(12):4, 6, 8. PubMed ID: 10026541
[No Abstract] [Full Text] [Related]
15. Effect of Medicare dialysis payment reform on use of erythropoiesis stimulating agents.
Swaminathan S; Mor V; Mehrotra R; Trivedi AN
Health Serv Res; 2015 Jun; 50(3):790-808. PubMed ID: 25355431
[TBL] [Abstract][Full Text] [Related]
16. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
Besarab A; McCrea JB
ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
[No Abstract] [Full Text] [Related]
17. A lesson from the EPO mess: stop the cost shifting.
Amerling R
Nephrol News Issues; 2007 Jul; 21(8):52, 54-5, 68. PubMed ID: 17688232
[No Abstract] [Full Text] [Related]
18. Medicare developments and explanations affecting nurse practitioners.
Sollins HL
Geriatr Nurs; 2006; 27(3):149-50. PubMed ID: 16757385
[No Abstract] [Full Text] [Related]
19. Overview of the Medicare and Medicaid programs.
Health Care Financ Rev Stat Suppl; 1999; ():1-348. PubMed ID: 12847762
[No Abstract] [Full Text] [Related]
20. An $18 billion problem. Nursing-care providers bemoan payment change.
Zigmond J
Mod Healthc; 2009 Aug; 39(32):10. PubMed ID: 19714841
[No Abstract] [Full Text] [Related]
[Next] [New Search]
